These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 6735000)

  • 1. [Aminoacidoagram in acromegaly patients].
    Morosini PP; Campanelia N; Butini L; Carletti P; Sabbatini A; Maniscalco L
    G Clin Med; 1984; 65(3-4):183-8. PubMed ID: 6735000
    [No Abstract]   [Full Text] [Related]  

  • 2. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of dopaminergic stimulation on growth hormone and prolactin in the treatment of acromegaly].
    Nedvídková J; Felt V
    Vnitr Lek; 1980 Oct; 26(10):988-93. PubMed ID: 7467150
    [No Abstract]   [Full Text] [Related]  

  • 4. Systolic time interval in acromegaly.
    Talwar KK; Sapru RP; Dash RJ; Rastogi GK; Wahi PL
    J Assoc Physicians India; 1979 Dec; 27(12):1075-8. PubMed ID: 549917
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of small doses of bromocriptine (Parlodel) on the serum level of growth hormone in acromegaly].
    Gáspár L; László F
    Orv Hetil; 1980 May; 121(20):1179-82. PubMed ID: 7413200
    [No Abstract]   [Full Text] [Related]  

  • 6. Regression of lung size in adults with growth hormone deficiency.
    De Troyer A; Desir D; Copinschi G
    Q J Med; 1980; 49(195):329-40. PubMed ID: 7465765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thyroliberin (TRH), bromocriptine and cyproheptadine on somatotropin secretion in acromegaly.
    Pawlikowski M; Strejczek H; Owczarczyk I; Komorowski J
    Mater Med Pol; 1980; 12(1-2):70-3. PubMed ID: 6799708
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly].
    Felt V; Nedvídková J
    Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061
    [No Abstract]   [Full Text] [Related]  

  • 9. Management and treatment of patients with acromegaly.
    Coskeran P
    Nurs Times; 1999 Mar 31-Apr 6; 95(13):50-2. PubMed ID: 10358581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acromegaly. Clinical and biochemical features in 500 patients.
    Ezzat S; Forster MJ; Berchtold P; Redelmeier DA; Boerlin V; Harris AG
    Medicine (Baltimore); 1994 Sep; 73(5):233-40. PubMed ID: 7934807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels.
    Matyja V; Kos-Kudla B; Foltyn W; Strzelczyk J; Latos W; Marek B; Kajdaniuk D; Karpe J; Ostrowska Z; Sieron-Stoltny K; Sieron A
    Neuro Endocrinol Lett; 2006 Oct; 27(5):639-43. PubMed ID: 17159821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
    Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G
    Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of growth hormone on sleep energy].
    Aström CP; Trojaborg W
    Ugeskr Laeger; 1994 Oct; 156(40):5849-52. PubMed ID: 7985277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine levels in acromegaly patients.
    Hekimsoy Z; Ozmen B; Ulusoy S
    Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum adiponectin levels in adult growth hormone deficiency and acromegaly.
    Fukuda I; Hizuka N; Ishikawa Y; Itoh E; Yasumoto K; Murakami Y; Sata A; Tsukada J; Kurimoto M; Okubo Y; Takano K
    Growth Horm IGF Res; 2004 Dec; 14(6):449-54. PubMed ID: 15519253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacodynamic analysis of octreotide in acromegalic patients.
    Comets E; Mentré F; Grass P; Kawai R; Marbach P; Vonderscher J
    Clin Pharmacol Ther; 2003 Jan; 73(1):95-106. PubMed ID: 12545148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acromegaly].
    Seige K; Ulrich FE
    Verh Dtsch Ges Inn Med; 1980; 86():67-72. PubMed ID: 7223044
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of growth hormone and other hormones on trabecular bone structure in acromegaly].
    Zák J; Kapitola J; Povýsil C; Haas T
    Sb Lek; 1999; 100(3):223-33. PubMed ID: 11221470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.